Anthem Biosciences Limited

Integrated Core Strategies bought 10,000 shares of Anthem Biosciences Limited for ₹74.48 lakh at ₹744.80 apiece in a block deal on June 18, 2026. This was part of a larger transaction where promoter Aruna Ganesh sold a 3.05% stake in the company.

A biotechnology company providing contract research, development, and manufacturing services alongside specialty ingredients production. Established in 2006, the company serves pharmaceutical and nutraceutical sectors through its integrated CRDMO capabilities and custom synthesis expertise. Its distinctive position lies in combining comprehensive development expertise with in-house manufacturing facilities, enabling end-to-end solutions for clients requiring specialized ingredient formulation, process optimization, and commercial-scale production services.

Investment vehicle of Millennium Management, a New York-based multi-strategy hedge fund.